Noble Wealth Management PBC’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.7K Sell
4
-3
-43% -$1.78K ﹤0.01% 560
2026
Q2
$3.51K Buy
7
+4
+133% +$1.92K ﹤0.01% 543
2026
Q1
$1.48K Sell
3
-16
-84% -$8.68K ﹤0.01% 560
2025
Q4
$11K Hold
19
– – 0.01% 449
2025
Q3
$9.21K Buy
+19
New +$8.84K ﹤0.01% 450
2025
Q1
$33.3K Hold
67
– – 0.02% 251
2024
Q4
$34.9K Buy
+67
New +$36.8K 0.02% 223

Other funds holding TMO

Noble Wealth Management PBC's TMO Position: Q3 2026 in Review

Noble Wealth Management PBC reduced its Thermo Fisher Scientific (TMO) stake by 43% in Q3 2026, selling an estimated $1.78K and leaving 4 shares worth $2.7K. The position accounts for ﹤0.01% of the portfolio, ranked #560.

Noble Wealth Management PBC first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $34.9K in Q4 2024. 134 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Noble Wealth Management PBC held 4 shares of Thermo Fisher Scientific worth $2.7K as of Q3 2026.
  • Noble Wealth Management PBC sold 3 Thermo Fisher Scientific shares in Q3 2026, an estimated $1.78K.
  • Thermo Fisher Scientific made up ﹤0.01% of Noble Wealth Management PBC's portfolio in Q3 2026, its #560 holding.
  • Noble Wealth Management PBC first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • Noble Wealth Management PBC's Thermo Fisher Scientific position peaked at $34.9K in Q4 2024.
  • 134 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Noble Wealth Management PBC's 13F filing for Q3 2026, filed 1 Oct 2026.